Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stemness as the Engine of Checkpoint Durability.

The New England journal of medicine·2026
Same author

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

Nature medicine·2026
Same author

Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease.

The New England journal of medicine·2026
Same author

NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advanced deep learning enables prediction of allogeneic stem cell mobilization success.

Bone marrow transplantation·2026
Same author

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.

Nature communications·2026

Related Experiment Video

Updated: Jun 6, 2026

Structured Motor Rehabilitation After Selective Nerve Transfers
09:34

Structured Motor Rehabilitation After Selective Nerve Transfers

Published on: August 15, 2019

Can every patient be mobilized?

John F DiPersio1

  • 1Washington University School of Medicine, St Louis, Missouri 63110, United States. jdipers@dom.wustl.edu

Best Practice & Research. Clinical Haematology
|December 7, 2010
PubMed
Summary
This summary is machine-generated.

Mobilizing hematopoietic stem cells (HSCs) is crucial for transplants. New agents like plerixafor enhance stem cell yield, improving patient survival by increasing the CD34+ cell dose.

More Related Videos

Use of a Foot-Induced Digitally Controlled Resistance Device for Functional Magnetic Resonance Imaging Evaluation in Patients with Foot Paresis
08:55

Use of a Foot-Induced Digitally Controlled Resistance Device for Functional Magnetic Resonance Imaging Evaluation in Patients with Foot Paresis

Published on: July 7, 2023

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Related Experiment Videos

Last Updated: Jun 6, 2026

Structured Motor Rehabilitation After Selective Nerve Transfers
09:34

Structured Motor Rehabilitation After Selective Nerve Transfers

Published on: August 15, 2019

Use of a Foot-Induced Digitally Controlled Resistance Device for Functional Magnetic Resonance Imaging Evaluation in Patients with Foot Paresis
08:55

Use of a Foot-Induced Digitally Controlled Resistance Device for Functional Magnetic Resonance Imaging Evaluation in Patients with Foot Paresis

Published on: July 7, 2023

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Cell Biology

Background:

  • Hematopoietic stem cell transplantation (HSCT) requires effective stem cell mobilization.
  • Current methods like G-CSF and chemotherapy have limitations.
  • Understanding the bone marrow microenvironment is key to optimizing stem cell collection.

Purpose of the Study:

  • To review methods for mobilizing hematopoietic stem cells (HSCs).
  • To highlight the role of novel agents in improving stem cell yield.
  • To emphasize the importance of achieving adequate CD34+ cell doses for successful engraftment and survival.

Main Methods:

  • Review of existing literature on stem cell mobilization techniques.
  • Discussion of pharmacological agents targeting the bone marrow microenvironment.
  • Analysis of CD34+ cell dose thresholds for engraftment and survival.

Main Results:

  • Granulocyte colony-stimulating factor (G-CSF) and chemotherapy are standard mobilization agents.
  • Novel agents, including CXCR4 inhibitors like plerixafor, enhance stem cell yield by disrupting stromal-stem cell interactions.
  • Higher CD34+ stem cell doses (e.g., 5 × 10⁶ cells/kg) are linked to improved survival post-transplant.

Conclusions:

  • Optimizing stem cell mobilization is critical for successful autologous and allogeneic HSCT.
  • Targeting the bone marrow microenvironment with agents like plerixafor offers improved stem cell collection.
  • Achieving higher CD34+ stem cell doses is associated with better patient outcomes and survival.